XVIVO, in collaboration with Wyant Simboli and their client, Arvinas Inc., helped communicate the unconventional mechanism of action for a new class of drugs that engage the body’s own protein disposal system to target cancers and other difficult-to-treat diseases.
To kick-off the New Year, we’re launching a fresh new showreel for XVIVO.
2018 was an exciting and rewarding year for the team at XVIVO Scientific Animation. We delved into new topics, such as neuroendocrine tumors and ciliary motility, we
The NIH Somatic Cell Genome Editing program is supporting development of new tools and tests that may one day bring more gene therapies to patients.
What if a disease could be treated by diving into a cell to edit the
As early as the 3rd century BC, scientists dedicated their lives to understand our innermost workings. But, thanks to virtual reality, you don’t need to be a scientist to discover how the body works on the cellular level. XVIVO Scientific
When the Englander Institute for Precision Medicine at Weill Cornell wanted to visualize their research on organoids they turned XVIVO.
For the animation’s visual arc we used 2d cutout cartoons that transition to a vibrant realistic 3d world. This approach